News Listing

HERCULES, Calif. — April 02, 2024 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.b), a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company’s Droplet Digital PCR (ddPCR™) offering for the oncology market, where highly ...

Antibodies Validated for Use with Bio-Rad’s Celselect Slides™ Enumeration Stain Kits to Enable Immunostaining of Captured Circulating Tumor Cells in Liquid Biopsy Samples.

Project will be a demonstration of how Ubiquigent’s DUB-centric platform can support the development of DUB inhibitors all the way from discovery through to clinical development.

Cancer Research Horizons, the innovation arm of Cancer Research UK, has announced the winners of its second Innovation & Entrepreneurship Awards.

THIS ANNOUNCEMENT, INCLUDING THE APPENDIX, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE ...

Produced using a patented dry-spinning technology - CollaFibR™ from AMSBIO is a highly consistent collagen fibre matrix that closely mimics the biomechanical and biochemical properties of natural collagen scaffolds, offering a highly accurate representation of in-vivo conditions.
These innovative collagen fibres are seamlessly produced on a commercial scale using an automated state-of-the-art ...

Following £2.3m of seed funding, Nium has relocated its HQ to Milton Park, where it hopes to innovate using nanotechnology to eliminate emissions from ammonia production (one of the planet’s most critical, yet polluting industrial processes).

Nium joins an increasing number of companies at Milton Park who are focused in the green energy sector, including Tokamak Energy, which is advancing ...

CryoLogyx, announces it has raised £500k in seed funding from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN). The funding will be used to support commercialization of pre-plated, assay-ready, cryopreserved cells for drug discovery, diagnostic and cell therapy applications.

Start-ups working in FemTech and women's health are urged to join a new growth programme hosted by Discovery Park, Kent's science park and R&D community. 

The programme offers tailored mentoring and support for start-ups, preparing founders for success in investment pitches. Companies will compete to win a support package worth over £50K, including 1 year of lab or office space at Discovery ...

Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s upcoming Phase IIb study following successful Phase Ib/IIa study